Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 67

1.

Finding Neo (antigens, that is).

Olweus J, Lund-Johansen F.

Blood. 2019 Jul 11;134(2):108-109. doi: 10.1182/blood.2019001334. No abstract available.

PMID:
31296544
2.

High-resolution antibody array analysis of proteins from primary human keratinocytes and leukocytes.

de la Rosa Carrillo D, Sikorski K, Khnykin D, Wu W, Lund-Johansen F.

PLoS One. 2018 Dec 27;13(12):e0209271. doi: 10.1371/journal.pone.0209271. eCollection 2018.

3.

A high-throughput pipeline for validation of antibodies.

Sikorski K, Mehta A, Inngjerdingen M, Thakor F, Kling S, Kalina T, Nyman TA, Stensland ME, Zhou W, de Souza GA, Holden L, Stuchly J, Templin M, Lund-Johansen F.

Nat Methods. 2018 Nov;15(11):909-912. doi: 10.1038/s41592-018-0179-8. Epub 2018 Oct 30.

PMID:
30377371
4.

Should we ignore western blots when selecting antibodies for other applications?

Lund-Johansen F, Browning MD.

Nat Methods. 2017 Feb 28;14(3):215. doi: 10.1038/nmeth.4192. No abstract available.

PMID:
28245212
5.

Novel serum and bile protein markers predict primary sclerosing cholangitis disease severity and prognosis.

Vesterhus M, Holm A, Hov JR, Nygård S, Schrumpf E, Melum E, Thorbjørnsen LW, Paulsen V, Lundin K, Dale I, Gilja OH, Zweers SJLB, Vatn M, Schaap FG, Jansen PLM, Ueland T, Røsjø H, Moum B, Ponsioen CY, Boberg KM, Färkkilä M, Karlsen TH, Lund-Johansen F.

J Hepatol. 2017 Jun;66(6):1214-1222. doi: 10.1016/j.jhep.2017.01.019. Epub 2017 Feb 2.

PMID:
28161472
6.

MetaMass, a tool for meta-analysis of subcellular proteomics data.

Lund-Johansen F, de la Rosa Carrillo D, Mehta A, Sikorski K, Inngjerdingen M, Kalina T, Røysland K, de Souza GA, Bradbury AR, Lecrevisse Q, Stuchly J.

Nat Methods. 2016 Oct;13(10):837-40. doi: 10.1038/nmeth.3967. Epub 2016 Aug 29.

PMID:
27571551
7.

[Letter to the Editor] The need for improved education and training in research antibody usage and validation practices.

Freedman LP, Gibson MC, Bradbury AR, Buchberg AM, Davis D, Dolled-Filhart MP, Lund-Johansen F, Rimm DL.

Biotechniques. 2016 Jul 1;61(1):16-8. doi: 10.2144/000114431. eCollection 2016.

8.

Targeting of cancer neoantigens with donor-derived T cell receptor repertoires.

Strønen E, Toebes M, Kelderman S, van Buuren MM, Yang W, van Rooij N, Donia M, Böschen ML, Lund-Johansen F, Olweus J, Schumacher TN.

Science. 2016 Jun 10;352(6291):1337-41. doi: 10.1126/science.aaf2288. Epub 2016 May 19.

9.

Antibody Engineering & Therapeutics, the annual meeting of The Antibody Society December 7-10, 2015, San Diego, CA, USA.

Pauthner M, Yeung J, Ullman C, Bakker J, Wurch T, Reichert JM, Lund-Johansen F, Bradbury AR, Carter PJ, Melis JP.

MAbs. 2016;8(3):617-52. doi: 10.1080/19420862.2016.1153211.

10.

High-resolution Antibody Array Analysis of Childhood Acute Leukemia Cells.

Kanderova V, Kuzilkova D, Stuchly J, Vaskova M, Brdicka T, Fiser K, Hrusak O, Lund-Johansen F, Kalina T.

Mol Cell Proteomics. 2016 Apr;15(4):1246-61. doi: 10.1074/mcp.M115.054593. Epub 2016 Jan 19.

11.

Enhanced liver fibrosis score predicts transplant-free survival in primary sclerosing cholangitis.

Vesterhus M, Hov JR, Holm A, Schrumpf E, Nygård S, Godang K, Andersen IM, Naess S, Thorburn D, Saffioti F, Vatn M, Gilja OH, Lund-Johansen F, Syversveen T, Brabrand K, Parés A, Ponsioen CY, Pinzani M, Färkkilä M, Moum B, Ueland T, Røsjø H, Rosenberg W, Boberg KM, Karlsen TH.

Hepatology. 2015 Jul;62(1):188-97. doi: 10.1002/hep.27825. Epub 2015 Apr 28.

PMID:
25833813
12.

Recombinant renewable polyclonal antibodies.

Ferrara F, D'Angelo S, Gaiotto T, Naranjo L, Tian H, Gräslund S, Dobrovetsky E, Hraber P, Lund-Johansen F, Saragozza S, Sblattero D, Kiss C, Bradbury AR.

MAbs. 2015;7(1):32-41. doi: 10.4161/19420862.2015.989047.

13.

Antibody engineering and therapeutics, The Annual Meeting of the Antibody Society: December 8-12, 2013, Huntington Beach, CA.

Almagro JC, Gilliland GL, Breden F, Scott JK, Sok D, Pauthner M, Reichert JM, Helguera G, Andrabi R, Mabry R, Bléry M, Voss JE, Laurén J, Abuqayyas L, Barghorn S, Ben-Jacob E, Crowe JE Jr, Huston JS, Johnston SA, Krauland E, Lund-Johansen F, Marasco WA, Parren PW, Xu KY.

MAbs. 2014 May-Jun;6(3):577-618. doi: 10.4161/mabs.28421. Epub 2014 Mar 3.

14.

Alloreactive cytotoxic T cells provide means to decipher the immunopeptidome and reveal a plethora of tumor-associated self-epitopes.

Kumari S, Wälchli S, Fallang LE, Yang W, Lund-Johansen F, Schumacher TN, Olweus J.

Proc Natl Acad Sci U S A. 2014 Jan 7;111(1):403-8. doi: 10.1073/pnas.1306549111. Epub 2013 Dec 16.

15.

An automated analysis of highly complex flow cytometry-based proteomic data.

Stuchlý J, Kanderová V, Fišer K, Cerná D, Holm A, Wu W, Hrušák O, Lund-Johansen F, Kalina T.

Cytometry A. 2012 Feb;81(2):120-9. doi: 10.1002/cyto.a.22011. Epub 2011 Dec 28.

16.

Multiplexed immuno-precipitation with 1725 commercially available antibodies to cellular proteins.

Slaastad H, Wu W, Goullart L, Kanderova V, Tjønnfjord G, Stuchly J, Kalina T, Holm A, Lund-Johansen F.

Proteomics. 2011 Dec;11(23):4578-82. doi: 10.1002/pmic.201000744. Epub 2011 Nov 7.

PMID:
21956872
17.

Antibody array analysis of labelled proteomes: how should we control specificity?

Holm A, Wu W, Lund-Johansen F.

N Biotechnol. 2012 Jun 15;29(5):578-85. doi: 10.1016/j.nbt.2011.07.008. Epub 2011 Aug 4.

PMID:
21840428
18.

Rapid generation of rotavirus-specific human monoclonal antibodies from small-intestinal mucosa.

Di Niro R, Mesin L, Raki M, Zheng NY, Lund-Johansen F, Lundin KE, Charpilienne A, Poncet D, Wilson PC, Sollid LM.

J Immunol. 2010 Nov 1;185(9):5377-83. doi: 10.4049/jimmunol.1001587. Epub 2010 Oct 8.

19.

Targeting B cell leukemia with highly specific allogeneic T cells with a public recognition motif.

Abrahamsen IW, Stronen E, Wälchli S, Johansen JN, Kjellevoll S, Kumari S, Komada M, Gaudernack G, Tjonnfjord G, Toebes M, Schumacher TN, Lund-Johansen F, Olweus J.

Leukemia. 2010 Nov;24(11):1901-9. doi: 10.1038/leu.2010.186. Epub 2010 Sep 16.

PMID:
20844564
20.

Dendritic cells engineered to express defined allo-HLA peptide complexes induce antigen-specific cytotoxic T cells efficiently killing tumour cells.

Stronen E, Abrahamsen IW, Gaudernack G, Wälchli S, Munthe E, Buus S, Johansen FE, Lund-Johansen F, Olweus J.

Scand J Immunol. 2009 Apr;69(4):319-28. doi: 10.1111/j.1365-3083.2008.02223.x.

21.

The monoclonal antibody 6B9 recognizes CD44 and not cell surface transglutaminase 2.

Stamnaes J, Fleckenstein B, Lund-Johansen F, Sollid LM.

Scand J Immunol. 2008 Nov;68(5):534-42. doi: 10.1111/j.1365-3083.2008.02173.x. Epub 2008 Sep 18.

22.

Antibody array analysis with label-based detection and resolution of protein size.

Wu W, Slåstad H, de la Rosa Carrillo D, Frey T, Tjønnfjord G, Boretti E, Aasheim HC, Horejsi V, Lund-Johansen F.

Mol Cell Proteomics. 2009 Feb;8(2):245-57. doi: 10.1074/mcp.M800171-MCP200. Epub 2008 Sep 16.

23.

Assay for monitoring in vitro selective depletion strategies in allogeneic stem cell transplantation.

Villa I, Kvale EO, Lund-Johansen F, Olweus J.

Cytotherapy. 2007;9(6):600-10.

PMID:
17882725
24.

High expression of CD7 on CD34+ cells is not linked to deletion of derivative chromosome 9 or lack of dendritic cells in chronic myeloid leukaemia.

Fløisand Y, Normann AP, Heim S, Lund-Johansen F, Tjønnfjord GE.

Scand J Clin Lab Invest. 2008;68(2):93-8. Epub 2007 Sep 12.

PMID:
17852828
25.

Plasmacytoid DCs regulate recall responses by rapid induction of IL-10 in memory T cells.

Kvale EO, Fløisand Y, Lund-Johansen F, Rollag H, Farkas L, Ghanekar S, Brandtzaeg P, Jahnsen FL, Olweus J.

Blood. 2007 Apr 15;109(8):3369-76. Epub 2006 Dec 7.

PMID:
17158235
26.

Signaling through toll-like receptor 7/8 induces the differentiation of human bone marrow CD34+ progenitor cells along the myeloid lineage.

Sioud M, Fløisand Y, Forfang L, Lund-Johansen F.

J Mol Biol. 2006 Dec 15;364(5):945-54. Epub 2006 Sep 27.

PMID:
17049554
27.
28.

CD11c+ dendritic cells and plasmacytoid DCs are activated by human cytomegalovirus and retain efficient T cell-stimulatory capability upon infection.

Kvale EØ, Dalgaard J, Lund-Johansen F, Rollag H, Farkas L, Midtvedt K, Jahnsen FL, Brinchmann JE, Olweus J.

Blood. 2006 Mar 1;107(5):2022-9. Epub 2005 Nov 3.

PMID:
16269620
29.

Plasmacytoid dendritic cells activate allergen-specific TH2 memory cells: modulation by CpG oligodeoxynucleotides.

Farkas L, Kvale EO, Johansen FE, Jahnsen FL, Lund-Johansen F.

J Allergy Clin Immunol. 2004 Aug;114(2):436-43.

PMID:
15316529
30.

Epidermal growth factor receptor inhibition induces trichomegaly.

Dueland S, Sauer T, Lund-Johansen F, Ostenstad B, Tveit KM.

Acta Oncol. 2003;42(4):345-6. No abstract available.

PMID:
12899508
31.

Involvement of plasmacytoid dendritic cells in human diseases.

Jahnsen FL, Farkas L, Lund-Johansen F, Brandtzaeg P.

Hum Immunol. 2002 Dec;63(12):1201-5. Review.

PMID:
12480264
32.

Plasmacytoid dendritic cells (natural interferon- alpha/beta-producing cells) accumulate in cutaneous lupus erythematosus lesions.

Farkas L, Beiske K, Lund-Johansen F, Brandtzaeg P, Jahnsen FL.

Am J Pathol. 2001 Jul;159(1):237-43.

33.

Experimentally induced recruitment of plasmacytoid (CD123high) dendritic cells in human nasal allergy.

Jahnsen FL, Lund-Johansen F, Dunne JF, Farkas L, Haye R, Brandtzaeg P.

J Immunol. 2000 Oct 1;165(7):4062-8.

34.
35.

[Dendritic cells--strong candidates for immunotherapy].

Lund-Johansen F, Olweus J.

Tidsskr Nor Laegeforen. 1999 Jun 30;119(17):2510-4. Review. Norwegian.

PMID:
10425906
36.

Primitive human hematopoietic progenitor cells express receptors for granulocyte-macrophage colony-stimulating factor.

Lund-Johansen F, Houck D, Hoffman R, Davis K, Olweus J.

Exp Hematol. 1999 Apr;27(4):762-72.

PMID:
10210334
37.

Transgene expression of bcl-xL permits anti-immunoglobulin (Ig)-induced proliferation in xid B cells.

Solvason N, Wu WW, Kabra N, Lund-Johansen F, Roncarolo MG, Behrens TW, Grillot DA, Nunez G, Lees E, Howard M.

J Exp Med. 1998 Apr 6;187(7):1081-91.

38.

Dendritic cell ontogeny: a human dendritic cell lineage of myeloid origin.

Olweus J, BitMansour A, Warnke R, Thompson PA, Carballido J, Picker LJ, Lund-Johansen F.

Proc Natl Acad Sci U S A. 1997 Nov 11;94(23):12551-6.

41.
43.

The "common stem cell" hypothesis reevaluated: human fetal bone marrow contains separate populations of hematopoietic and stromal progenitors.

Waller EK, Olweus J, Lund-Johansen F, Huang S, Nguyen M, Guo GR, Terstappen L.

Blood. 1995 May 1;85(9):2422-35.

PMID:
7537114
44.

CD64/Fc gamma RI is a granulo-monocytic lineage marker on CD34+ hematopoietic progenitor cells.

Olweus J, Lund-Johansen F, Terstappen LW.

Blood. 1995 May 1;85(9):2402-13.

PMID:
7537112
45.
46.

Flow cytometric assessment of peripheral blood contamination and proliferative activity of human bone marrow cell populations.

Abrahamsen JF, Lund-Johansen F, Laerum OD, Schem BC, Sletvold O, Smaaland R.

Cytometry. 1995 Jan 1;19(1):77-85.

47.

Expression of cell surface markers during differentiation of CD34+, CD38-/lo fetal and adult bone marrow cells.

Olweus J, Lund-Johansen F, Terstappen LW.

Immunomethods. 1994 Dec;5(3):179-88.

PMID:
7540098
48.

Commentary: hematopoietic progenitors in fetal and adult tissue.

Terstappen LW, Lund-Johansen F.

Blood Cells. 1994;20(2-3):392-6. No abstract available.

PMID:
7538344
49.

Activation of human monocytes and granulocytes by monoclonal antibodies to glycosylphosphatidylinositol-anchored antigens.

Lund-Johansen F, Olweus J, Symington FW, Arli A, Thompson JS, Vilella R, Skubitz K, Horejsi V.

Eur J Immunol. 1993 Nov;23(11):2782-91.

PMID:
8223854
50.

CD53, a protein with four membrane-spanning domains, mediates signal transduction in human monocytes and B cells.

Olweus J, Lund-Johansen F, Horejsi V.

J Immunol. 1993 Jul 15;151(2):707-16.

PMID:
8335905

Supplemental Content

Loading ...
Support Center